Cat. No.: X23-10-ZQ420
JAK inhibitor TCS 21311, Purity ≥98%
Synonym: TCS 21311; 1260181-14-3; NIBR3049; 3-[5-[4-(2-Hydroxy-2-methyl-1-oxopropyl)-1-piperazinyl]-2-(trifluoromethyl)phenyl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione; TCS-21311; CLGRAWDGLMENOD-UHFFFAOYSA-N; JAK inhibitor
- CAS Number: 1260181-14-3
- Compound CID: 50925411
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
TCS 21311 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets GSK-3β, JAK1, JAK2, JAK3, PKCα, and PKCθ.
Molecular Formula
C27H25F3N4O4
Targets
GSK-3β: 3 nM; JAK1: 1.017 μM; JAK2: 2.55 μM; JAK3: 8 nM; PKCα: 13 nM; PKCθ: 68 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
TCS 21311 can be used to explore the inhibition of Tyk2 and JAK1/2 kinase activity in autoimmune and inflammatory conditions.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links